Details

Autor(en) / Beteiligte

• Louie, Brian E
• Smith, C Daniel
• Smith, Christopher C
• Bell, Reginald C W
• Gillian, George Kevin
• Mandel, Jeffrey S
• Perry, Kyle A
• Birkenhagen, Walter Kurt
• Taiganides, Paul A
• Dunst, Christy M
• McCollister, Howard M
• Lipham, John C
• Khaitan, Leena K
• Tsuda, Shawn T
• Jobe, Blair A
• Kothari, Shanu N
• Gould, Jon C

Titel

Objective Evidence of Reflux Control After Magnetic Sphincter Augmentation: One Year Results From a Post Approval Study

Ist Teil von

• Annals of surgery, 2019-08, Vol.270 (2), p.302

Ort / Verlag

United States

Erscheinungsjahr

2019

Link zum Volltext

Beschreibungen/Notizen

• To report 1-year results from a 5-year mandated study. In 2012, the United States Food and Drug Administration approved magnetic sphincter augmentation (MSA) with the LINX Reflux Management System (Torax Medical, Shoreview, MN), a novel device for the surgical treatment of gastroesophageal reflux disease (GERD). Continued assessment of safety and effectiveness has been monitored in a Post Approval Study. Multicenter, prospective study of patients with pathologic acid reflux confirmed by esophageal pH testing undergoing MSA. Predefined clinical outcomes were assessed at the annual visit including a validated, disease-specific questionnaire, esophagogastricduodenoscopy and esophageal pH monitoring, and use of proton pump inhibitors. A total of 200 patients (102 males, 98 females) with a mean age of 48.5 years (range 19.7-71.6) were treated with MSA between March 2013 and August 2015. At 1 year, the mean total acid exposure time decreased from 10.0% at baseline to 3.6%, and 74.4% of patients had normal esophageal acid exposure time (% time pH<4 ≤5.3%). GERD Health-Related Quality of Life scores improved from a median score of 26.0 at baseline to 4.0 at 1 year, with 84% of patients meeting the predefined success criteria of at least a 50% reduction in total GERD Health-Related Quality of Life score compared with baseline. The device removal rate at 1 year was 2.5%. One erosion and no serious adverse events were reported. Safety and effectiveness of magnetic sphincter augmentation has been demonstrated outside of an investigational setting to further confirm MSA as treatment for GERD.